Approval · Notice of Compliance 9099 · 2007
BELESSE 21: Notice of Compliance 9099
Issued October 16, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9099
- Date
- October 16, 2007
- Company
- Wyeth CanadaSt. Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- Oral contraceptive
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BELESSE 21 | 02300621 | — |
| BELESSE 28 | 02300613 | — |
Medicinal ingredients
- LEVONORGESTREL 0.1 MG per TAB
- ETHINYL ESTRADIOL 0.02 MG per TAB